Novaken Pharm

Guangzhou, China · Founded 2007 · In IPO Registration

Manufacturer of medicines and health products intended to control drug release, sustained release and targeted drug release. Novaken Pharm is based in Guangzhou, China and was founded in 2007. Its last reported valuation was $215 million in Nov 2025. It has raised $39.1 million.

Last reported valuation

$215.1M

Oct 2026

Priced at

—

Total raised

$39.1M

Last round

—

How much has Novaken Pharm raised?

$39.1Macross 0 recorded rounds

Free account

More of Novaken Pharm with a free account

·Watch Novaken Pharm: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Novaken Pharm investors

9 investors are on record for Novaken Pharm, including Zhuhai Gree Financial Investment, ZJVC Venture Capital, Taiyou Fund and Lianyungang Jinhai Venture Capital.

For fundraisers

Raising for a company like Novaken Pharm?

9 investors have backed Novaken Pharm.

See all 9 investors →

Frequently asked about Novaken Pharm

How much has Novaken Pharm raised?: Novaken Pharm has raised $39.1M in total across 0 recorded funding rounds.